CClinicalTrials.gg
CompletedNCT05108181MT-STUpdated Apr 12, 2024

Muscle Typology and Strength Training Adaptations

An interventional study of Muscle typology + exercise training and Muscle typology + training frequency in Muscle Fiber Type, Exercise and Training Frequency, sponsored by University Ghent. Completed at 1 site in Belgium. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-04-12.

Sponsored by University Ghent · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Study summary

The overall aim of this project is to investigate if the responsiveness to chronic resistance training is dependent on the muscle typology. In a second aim we will investigate the most optimal training frequency for slow-twitchers and fast-twitchers. For the latter we hypothesize that slow-twitchers might cope better with higher frequencies and higher volumes compared to fast-twitchers.

Male and female adult participants (18-45y) will be recruited. The subjects' muscle typology will be non-invasively estimated in the leg muscles by measurement of muscle carnosine using H-MRS. In total 21 subjects (11 slow and 10 fast subjects) will participate. Subjects will be assigned to a whole-body resistance training exercise protocol of 9 weeks in wich arm A and leg A will train 3 times per week and arm B and leg B will train 2 times per week. Before and following the training period, subjects will be subjected to different measurements (fitness level, muscle volume, strength tests, blood sampling, muscle biopsies).

02

Conditions studied

  • Muscle Fiber Type
  • Exercise
  • Training Frequency

Keywords

  • Strength training
  • Muscle typology
03

In context

Lead sponsor

University Ghent is the lead sponsor of 345 studies on the registry; 85 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Fast or slow muscle typology
  • 18 - 45 years old
  • no strength training experience

Exclusion criteria

Exclusion Criteria:

  • Vegan/vegeterian diet
  • Supplement intake
  • chronic diseases
  • Hypertension,
  • Smoking
  • Medication use
  • Coagulation disorder, infectious diseases
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
60 participants (actual)

Study arms

  • Active comparator
    Slow muscle typology group

    The participants receive the same exercise training intervention, but they are divided in two groups: a slow typology group and a fast typology group based on their inherent physiological characteristics: their muscle fiber type.

    Other: Muscle typology + exercise training · Other: Muscle typology + training frequency

  • Active comparator
    Fast muscle typology group

    The participants receive the same exercise training intervention, but they are divided in two groups: a slow typology group and a fast typology group based on their inherent physiological characteristics: their muscle fiber type.

    Other: Muscle typology + exercise training · Other: Muscle typology + training frequency

Interventions

  • OtherMuscle typology + exercise training

    Exercise training: Participants perform 9 weeks of strength training at 60% of their 1RM.

  • OtherMuscle typology + training frequency

    Training frequency: leg A and arm A of the participants train 3 times per week, leg B and arm B train 2 times per week.

06

What researchers measure

Primary outcomes

  1. Change from baseline muscle volume at 9 weeks

    Muscle volume of the legs and the upper arms - MRI

    Time frame: Pre and post the 9 weeks training period

  2. Change from baseline dynamic muscle strength at 3 weeks

    Upper legs and upper arms - strength training devices

    Time frame: Pre, mid and post 9 weeks training period

  3. Change from baseline dynamic muscle strength at 6 weeks

    Upper legs and upper arms - strength training devices

    Time frame: Pre, mid and post 9 weeks training period

  4. Change from baseline dynamic muscle strength at 9 weeks

    Upper legs and upper arms - strength training devices

    Time frame: Pre, mid and post 9 weeks training period

  5. Change from baseline isometric muscle strength at 9 weeks

    Upper legs and upper arms - Biodex

    Time frame: Pre and post 9 weeks training period

  6. Change in muscle fiber type specific hypertrophy at 9 weeks

    Legs - Biopsy (vastus lateralis)

    Time frame: Pre and post 9 weeks training period

Secondary outcomes

  1. Change of baseline antropometry at 9 weeks

    Height, weight, skinfolds

    Time frame: Pre and post 9 weeks training period

  2. Change of baseline skeletal muscle protein content at 9 weeks

    Histochemistry and protein content of markers of relevance for skeletal muscle function

    Time frame: Pre and post 9 weeks training period

  3. Change of baseline histochemistry at 9 weeks

    Histochemistry of markers of relevance for skeletal muscle function

    Time frame: Pre and post 9 weeks training period

  4. Change from basline fatigue feeling over 9 weeks training period

    Number of repetitions during every training, questionnaire (VAS-scale) before every training, RPE after every training

    Time frame: Assessed every training during the 9 weeks training period

  5. Change from baseline fasting insulin, glucose, cholesterol and triglycerides at 9 weeks

    Fasted blood samples

    Time frame: Pre and post 9 weeks training period

07

Study locations

1 site
  • Department of Movement and Sports Sciences, Ghent University
    Gent, Oost-Vlaanderen 9000, Belgium
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 12, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05108181
Lead sponsor
University Ghent
Responsible party
Sponsor
First posted
Nov 4, 2021
Start date
Sep 9, 2021
Primary completion
Dec 8, 2023
Completion
Dec 8, 2023
Last update
Apr 12, 2024

Study contacts

Wim Derave
principal investigator · University Ghent

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion